Christina G. Kuhn

Christina Kuhn is an associate in the firm’s Washington, DC office, where she is a member of the Food and Drug and Litigation practice groups.  She provides pharmaceutical and medical device companies advice on a variety of federal and state regulatory matters.

Representative Matters

• Representation of a leading biotechnology firm in Food and Drug Administration proceedings relating to withdrawal of approval for a product.
• Representation of a major pharmaceutical company in government investigation.
• Advised pharmaceutical company regarding state manufacturer and wholesale distribution licensing requirement.
• Advised pharmaceutical company regarding over-the-counter drug labeling.

Previous Experience

• United States Attorney’s Office for the Southern District of New York, Civil Division, Intern (2010)
• New York County District Attorney’s Office, Paralegal (2005-2006)

Pro Bono

• Incorporation of a tenants association and representation of the association under the D.C. Tenant Opportunity to Purchase Act.
• Favorable settlement for a non-profit mental health services agency in response to a race discrimination claim by a terminated employee filed with the District of Columbia Office of Human Rights.

Memberships and Affiliations

• New York State Bar Association

Publications and Speeches

• "FDA Proposes UDI System for Medical Devices," Journal of Medical Device Regulation (August 2012), Co-Author
• "FDA Issues Proposed Rule to Establish a Unique Device Identification System for Medical Devices," Covington Advisory (7/16/2012), Co-Author
• "FDA Issues Draft Guidance on Evaluating Substantial Equivalence in 510(k) Premarket Notifications," Covington E-Alert (2/7/2012), Co-Author